Neonc Technologies Holdings, Inc. balance sheet
At the end of fiscal 2025, Neonc Technologies Holdings, Inc. had total assets of $2.8m, total liabilities of $20.3m and shareholders' equity of −$17.5m. It held $58,729 in cash against $6.0m of debt: net debt of $5.9m.
Balance sheet
| Fiscal year | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|
| Cash and equivalents | 0 | 0 |
| Total current assets | 2 | 1 |
| Total assets | 3 | 3 |
| Accounts payable | 3 | — |
| Total current liabilities | 9 | 20 |
| Total debt | 0 | 6 |
| Total liabilities | 9 | 20 |
| Shareholders' equity | −6 | −18 |
| Net debt (negative = net cash) | −0 | 6 |
| Shares outstanding | 18m | 22m |
| Quarter | 2024 Q2Jun 2024 | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | — | — | 2 | 7 | 2 | 3 | 1 | 4 |
| Total assets | — | — | 3 | 8 | 3 | 4 | 3 | 5 |
| Accounts payable | — | — | 3 | 4 | 3 | — | — | — |
| Total current liabilities | — | — | 9 | 18 | 14 | 16 | 20 | 24 |
| Total liabilities | — | — | 9 | — | 15 | 16 | 20 | 24 |
| Shareholders' equity | −6 | −5 | −6 | −10 | −12 | −12 | −18 | −19 |
| Shares outstanding | — | — | 18m | 19m | 19m | 19m | 22m | 26m |
Compare with peers
- Lyell Immunopharma, Inc. balance sheet
- AIM Immunotech Inc. balance sheet
- Ibio, Inc. balance sheet
- Lisata Therapeutics, Inc. balance sheet
- Celldex Therapeutics, Inc. balance sheet
Head to head: LYEL vs NTHIAIM vs NTHIIBIO vs NTHI
More: Biotechnology stocks compared, Health Care sector, rankings of US companies